Vanguard Group
GBIM

Vanguard Group’s GLOBEIMMUNE INC COM STK (DE) GBIM Stock Holding History

Vanguard Group’s Portfolio GBIM Stock Details GBIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-24,401
Closed -$47K – 4151
2016
Q2 		$47K Buy
24,401
+1,595
+7% +$2.83K ﹤0.01% 4082
2016
Q1 		$47K Buy
22,806
+11,888
+109% +$25.8K ﹤0.01% 4085
2015
Q4 		$43K Buy
+10,918
New +$34.9K ﹤0.01% 4141

Other funds holding GBIM

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group's GBIM Position: Q3 2016 in Review

Vanguard Group sold out of GLOBEIMMUNE INC COM STK (DE) (GBIM) in Q3 2016, closing a stake of 24,401 shares — an estimated $47K sold.

Vanguard Group first reported a position in GBIM in Q4 2015 and held it in 3 quarters. The position peaked at $47K in Q2 2016. 1 fund tracked by Wall St. Rank holds GBIM as of Q3 2016.

  • Vanguard Group reported no remaining GLOBEIMMUNE INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Vanguard Group sold 24,401 GLOBEIMMUNE INC COM STK (DE) shares in Q3 2016, an estimated $47K.
  • Vanguard Group first reported a position in GLOBEIMMUNE INC COM STK (DE) in Q4 2015 and held it in 3 quarters.
  • Vanguard Group's GLOBEIMMUNE INC COM STK (DE) position peaked at $47K in Q2 2016.
  • 1 fund tracked by Wall St. Rank held GLOBEIMMUNE INC COM STK (DE) as of Q3 2016.

Based on Vanguard Group's 13F filing for Q3 2016, filed 14 Nov 2016.